Chemoinformaics analysis of Scutevulin
Molecular Weight | 300.266 | nRot | 2 |
Heavy Atom Molecular Weight | 288.17 | nRig | 18 |
Exact Molecular Weight | 300.063 | nRing | 3 |
Solubility: LogS | -3.782 | nHRing | 1 |
Solubility: LogP | 3.358 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
nHA | 6 | APOL | 39.5335 |
nHD | 3 | BPOL | 16.3785 |
QED | 0.672 |
Synth | 2.511 |
Natural Product Likeliness | 1.483 |
NR-PPAR-gamma | 0.957 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.021 |
HIA | 0.022 |
CACO-2 | -4.944 |
MDCK | 0.0000129 |
BBB | 0.006 |
PPB | 0.960356 |
VDSS | 0.508 |
FU | 0.0815088 |
CYP1A2-inh | 0.973 |
CYP1A2-sub | 0.788 |
CYP2c19-inh | 0.343 |
CYP2c19-sub | 0.059 |
CYP2c9-inh | 0.773 |
CYP2c9-sub | 0.84 |
CYP2d6-inh | 0.65 |
CYP2d6-sub | 0.331 |
CYP3a4-inh | 0.452 |
CYP3a4-sub | 0.134 |
CL | 5.476 |
T12 | 0.825 |
hERG | 0.051 |
Ames | 0.663 |
ROA | 0.103 |
SkinSen | 0.782 |
Carcinogencity | 0.212 |
EI | 0.913 |
Respiratory | 0.211 |
NR-Aromatase | 0.909 |
Antiviral | Yes |
Prediction | 0.769021 |